Inhibition of HIV-1 replication by a high-copy-number vector expressing antisense RNA for reverse transcriptase

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Developing efficient expression vectors is crucial for genetic engineering and therapeutic applications.
• Antisense RNA technology offers a strategy to inhibit viral replication.
• High-copy-number vectors can enhance the expression of therapeutic molecules.

Purpose of the Study:

• To construct and evaluate a high-copy-number (hcn) expression vector for human cells.
• To assess the efficacy of the hcn vector in inhibiting HIV-1 replication using antisense RNA.
• To explore the potential of this vector for genetic engineering and gene therapy.

Main Methods:

• Construction of a novel high-copy-number (hcn) expression vector incorporating a murine ribosomal DNA (rDNA) element.
• Expression of antisense RNA targeting the HIV-1 reverse transcriptase gene from the hcn vector in Jurkat T lymphocytes.
• Comparison of viral replication levels between cells transfected with the hcn vector and a control plasmid.

Main Results:

• The hcn vector significantly reduced HIV-1 replication in Jurkat T lymphocytes when expressing antisense RNA against reverse transcriptase.
• A control plasmid lacking the amplification element showed only a minor reduction in viral replication.
• The murine rDNA-derived element facilitated high-copy-number amplification of the expression vector.

Conclusions:

• The developed hcn expression vector is effective in suppressing HIV-1 replication.
• This vector system represents a significant advancement for eukaryotic genetic engineering.
• The hcn vector holds potential for future gene therapy strategies against viral diseases.